Evidence at the 2026 Executive War College suggests a coming push in clinical lab advocacy, focusing on the RESULTS Act to establish a permanent, database-driven reimbursement model. Simultaneously, federal regulators have floated the idea of heightened scrutiny of genetic test spending, signaling that while lab test reimbursement rates may stabilize, compliance oversight could enter a […]
Expect RESULTS Act Vote by the End of the Year
Also in the May 26, 2026 issue, we examine Roche's deal to acquire Path AI
- By Robert Michel
- > From the Volume XXXIII, No. 7 - May 26, 2026 Issue
